Critical medicine topic-CMT 004

CHAGAS' DISEASE

(AMERICAN TRYPANOSOMIASIS) 

15.1A: Chagas Disease (American Trypanosomiasis) - Biology LibreTexts

 Definition

Chagas' disease is a parasitic infection caused by the protozoan Trypanosoma cruzi. The major cardiovascular manifestation is extensive myocarditis, which eventually leads to dilated cardiomyopathy and congestive heart failure. The disease usually becomes clinically evident 20–30 years after the initial infection.


Epidemiology

  • Endemic in Central and South America.
  • Approximately 10–20 million people are infected.
  • The disease is an important cause of non-ischemic dilated cardiomyopathy in endemic regions.

Etiology

  • Caused by the protozoan parasite Trypanosoma cruzi.
  • Transmitted to humans by the bite of the reduviid bug (kissing bug) during the acute phase of infection.

Phases of Chagas' Disease

1. Acute Phase

  • Infection occurs following the bite of the kissing bug.
  • Protozoa multiply rapidly and spread throughout the body.
  • The acute illness is often mild or asymptomatic.

2. Latent (Indeterminate) Phase

  • Parasites persist within the host with few or no clinical manifestations.
  • This phase may last for several decades.

3. Chronic Phase

  • Develops in approximately 30% of infected individuals.
  • Characterized by progressive myocardial damage, arrhythmias, and heart failure.
  • Interestingly, many individuals with a high parasite burden never develop chronic disease, while parasites may not be detectable in patients dying from Chagas' disease, suggesting that an autoimmune mechanism contributes to cardiac injury.

Pathogenesis

  • Chronic myocarditis causes progressive destruction of myocardial tissue.
  • Cardiac dysfunction may result from both:
    • Persistent infection with Trypanosoma cruzi, and
    • An autoimmune-mediated myocardial injury.
  • Cardiac parasympathetic denervation is a characteristic pathological feature.

Pathology (Autopsy Findings)

Typical autopsy findings include:

  • Extensive myocarditis.
  • Cardiac parasympathetic denervation.
  • Marked cardiomegaly.
  • Dilatation and hypertrophy of all cardiac chambers.
  • Thin, bulging left ventricular apical aneurysm.
  • Frequent mural thrombus formation, particularly within the left ventricular apex.

Clinical Features

Heart Failure

  • Chronic progressive congestive heart failure.
  • Predominantly right-sided heart failure in advanced disease.
  • Severe cardiomegaly is usually present.

Arrhythmias

  • Ventricular arrhythmias are a prominent feature.
  • Conduction abnormalities are common.

Electrocardiographic (ECG) Findings

The most common ECG abnormalities include:

  • Right bundle branch block (RBBB).
  • Left anterior hemiblock (left anterior fascicular block).
  • T-wave abnormalities.
  • Atrioventricular (AV) block.
  • Ventricular arrhythmias.

Diagnosis

Diagnosis is established by:

  • Complement-fixation test (Machado–Guerreiro test).

Treatment

  • No clinically effective treatment is available for advanced chronic Chagas' cardiomyopathy.
  • Current management is mainly supportive, including treatment of heart failure and arrhythmias.
  • Immunoprophylaxis with a vaccine remains a future hope.

Key Points

  • Caused by Trypanosoma cruzi.
  • Transmitted by the kissing bug (reduviid bug).
  • Endemic in Central and South America.
  • Clinical disease usually appears 20–30 years after infection.
  • Only about 30% of infected individuals develop chronic Chagas' disease.
  • Major cardiac manifestation is dilated cardiomyopathy with congestive heart failure.
  • Characteristic pathology includes left ventricular apical aneurysm and mural thrombus.
  • Common ECG findings are RBBB, left anterior hemiblock, AV block, and ventricular arrhythmias.
  • Diagnosis is by the Machado–Guerreiro complement-fixation test.
  • No definitive curative therapy is currently available for chronic disease.

DR.C.GANESAN M.D.,

PROFESSOR OF MEDICINE

 

No comments:

Post a Comment

SPECIAL SELECTED TOPICS- RESPIRATORY SYSTEM DISORDERS-SSTRSDO-QAA 028 1. What are the main characteristics of bronchogenic carcinomas? Bronc...